Kasner, S. E., Swaminathan, B., Lavados, P. M., Sharma, M., Muir, K. W., Veltkamp, R., . . . Baumgartner, P. (2018). Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: A prespecified subgroup analysis from the NAVIGATE ESUS trial.
Citace podle Chicago (17th ed.)Kasner, Scott E., et al. Rivaroxaban or Aspirin for Patent Foramen Ovale and Embolic Stroke of Undetermined Source: A Prespecified Subgroup Analysis from the NAVIGATE ESUS Trial. 2018.
Citace podle MLA (9th ed.)Kasner, Scott E., et al. Rivaroxaban or Aspirin for Patent Foramen Ovale and Embolic Stroke of Undetermined Source: A Prespecified Subgroup Analysis from the NAVIGATE ESUS Trial. 2018.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..